» Articles » PMID: 26220195

Allelic Mutations in Noncoding Genomic Sequences Construct Novel Transcription Factor Binding Sites That Promote Gene Overexpression

Overview
Date 2015 Jul 30
PMID 26220195
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

The growth and survival factor hepatocyte growth factor (HGF) is expressed at high levels in multiple myeloma (MM) cells. We report here that elevated HGF transcription in MM was traced to DNA mutations in the promoter alleles of HGF. Sequence analysis revealed a previously undiscovered single-nucleotide polymorphism (SNP) and crucial single-nucleotide variants (SNVs) in the promoters of myeloma cells that produce large amounts of HGF. The allele-specific mutations functionally reassembled wild-type sequences into the motifs that affiliate with endogenous transcription factors NFKB (nuclear factor kappa-B), MZF1 (myeloid zinc finger 1), and NRF-2 (nuclear factor erythroid 2-related factor 2). In vitro, a mutant allele that gained novel NFKB-binding sites directly responded to transcriptional signaling induced by tumor necrosis factor alpha (TNFα) to promote high levels of luciferase reporter. Given the recent discovery by genome-wide sequencing (GWS) of numerous non-coding mutations in myeloma genomes, our data provide evidence that heterogeneous SNVs in the gene regulatory regions may frequently transform wild-type alleles into novel transcription factor binding properties to aberrantly interact with dysregulated transcriptional signals in MM and other cancer cells.

Citing Articles

Zinc Finger Transcription Factor MZF1-A Specific Regulator of Cancer Invasion.

Brix D, Clemmensen K, Kallunki T Cells. 2020; 9(1).

PMID: 31963147 PMC: 7016646. DOI: 10.3390/cells9010223.


Comprehensive Characterization of Somatic Mutations Impacting lncRNA Expression for Pan-Cancer.

Gao Y, Li X, Zhi H, Zhang Y, Wang P, Wang Y Mol Ther Nucleic Acids. 2019; 18:66-79.

PMID: 31525663 PMC: 6745513. DOI: 10.1016/j.omtn.2019.08.004.


Role of the zinc finger and SCAN domain-containing transcription factors in cancer.

Huang M, Chen Y, Han D, Lei Z, Chu X Am J Cancer Res. 2019; 9(5):816-836.

PMID: 31218096 PMC: 6556609.


The repetitive DNA element BncDNA, enriched in the B chromosome of the cichlid fish Astatotilapia latifasciata, transcribes a potentially noncoding RNA.

Ramos E, Cardoso A, Brown J, Marques D, Fantinatti B, Cabral-de-Mello D Chromosoma. 2016; 126(2):313-323.

PMID: 27169573 DOI: 10.1007/s00412-016-0601-x.


Systematic analysis of somatic mutations driving cancer: uncovering functional protein regions in disease development.

Meszaros B, Zeke A, Remenyi A, Simon I, Dosztanyi Z Biol Direct. 2016; 11:23.

PMID: 27150584 PMC: 4858844. DOI: 10.1186/s13062-016-0125-6.

References
1.
Annunziata C, Davis R, Demchenko Y, Bellamy W, Gabrea A, Zhan F . Frequent engagement of the classical and alternative NF-kappaB pathways by diverse genetic abnormalities in multiple myeloma. Cancer Cell. 2007; 12(2):115-30. PMC: 2730509. DOI: 10.1016/j.ccr.2007.07.004. View

2.
Tjin E, Derksen P, Kataoka H, Spaargaren M, Pals S . Multiple myeloma cells catalyze hepatocyte growth factor (HGF) activation by secreting the serine protease HGF-activator. Blood. 2004; 104(7):2172-5. DOI: 10.1182/blood-2003-12-4386. View

3.
Morgan G, Walker B, Davies F . The genetic architecture of multiple myeloma. Nat Rev Cancer. 2012; 12(5):335-48. DOI: 10.1038/nrc3257. View

4.
Weinhold N, Jacobsen A, Schultz N, Sander C, Lee W . Genome-wide analysis of noncoding regulatory mutations in cancer. Nat Genet. 2014; 46(11):1160-5. PMC: 4217527. DOI: 10.1038/ng.3101. View

5.
Seidel C, Borset M, Turesson I, Abildgaard N, Sundan A, Waage A . Elevated serum concentrations of hepatocyte growth factor in patients with multiple myeloma. The Nordic Myeloma Study Group. Blood. 1998; 91(3):806-12. View